>>ACADIA Pharmaceuticals Announces Proposed Public Stock Offering
Monday April 2, 6:00 am ET
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD - News) announced today the filing of a preliminary prospectus supplement to its effective shelf registration statement previously filed with the Securities and Exchange Commission relating to a proposed underwritten public offering of 5,000,000 shares of its common stock. In connection with the offering, ACADIA also plans to grant the underwriters an option to purchase up to 750,000 additional shares of its common stock. All of the shares are being sold by ACADIA.
The book-running managers for the offering are Banc of America Securities LLC and Lehman Brothers Inc., the co-lead manager is Deutsche Bank Securities Inc., and the co-managers are Piper Jaffray & Co., JMP Securities LLC and Rodman & Renshaw, LLC.<<
snip
Stock is off over 6% now, and it got dissed by Cramer, who likely got wind of this. Probably a smart move by ACAD, but currently, I'm glad to have bailed my Mom out at $15. 103 does address a huge market, though. Even though I am concerned about 104, I'll be watching for an attractive re-entry point. Anyone have a feel for when we might hear news from the Allergan front?
Cheers, Tuck |
